Product Images Xeloda

This appears to be a chemical structure diagram with labels for various molecular components including Capecitabine, 5-DFUR, S5FU, dThdP, HG, and Cyd deaminase. The inclusion of the term "Carboxylesterase" suggests that the diagram is related to drug metabolism.*

The text appears to be a graph or a chart with various annotations and labels. The first word "Estimated" possibly indicates that the data or results are approximations. The word "Probability" is misspelled as "Probadity." The other text consists of numbers and abbreviations such as "Xeloda," "mg/sqm," and "intermittent," which may indicate medication dosages or treatment methods. The figure also has a scale on the x-axis labeled "Time (Days)" and a scale on the y-axis labeled from 0 to 10, possibly indicating the intensity or severity of a condition or disease. Without more context or information, it is not possible to provide a more specific description.*

This text appears to be a table showing estimated probabilities for a treatment plan that includes Dacetaxel, Eloxatin, and Xeloda over a certain period of time. The numbers in the table range from 0 to 10, with increments of 0.1 or 1, and are likely probabilities of successful treatment. The columns list the specific drugs used in the treatment plan. The final row appears to show a graph where time is plotted against dosage levels. No further context or information is provided in the text.*

Xeloda is a medication that comes in the form of 150 mg tablets. Each tablet contains 150 mg of the active ingredient capecitabine. The National Drug Code (NDC) for this medication is 0004-1100-20 and it is manufactured by Genentech. This is a prescription-only medication.*

Xeloda® is a medication manufactured by Genentech. Each tablet contains 500 mg of capecitabine. The medication is available in a bottle of 120 tablets. The National Drug Code (NDC) for this medication is 0004-1101-50.*